This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1995 Oct;40(10):2117-8.

doi: 10.1007/BF02208993.

Development of granulomatous hepatitis during treatment with interferon-alpha 2b

A Propst, T Propst, O Dietze, H Kathrein, G Judmeier, W Vogel

PMID: 7587776
DOI: 10.1007/BF02208993

Case Reports

Development of granulomatous hepatitis during treatment with interferon-alpha 2b

A Propst et al. Dig Dis Sci. 1995 Oct.

. 1995 Oct;40(10):2117-8.

doi: 10.1007/BF02208993.

Authors

A Propst, T Propst, O Dietze, H Kathrein, G Judmeier, W Vogel

PMID: 7587776
DOI: 10.1007/BF02208993

No abstract available

PubMed Disclaimer

Similar articles

Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha.
Veerabagu MP, Finkelstein SD, Rabinovitz M. Veerabagu MP, et al. Dig Dis Sci. 1997 Jul;42(7):1445-8. doi: 10.1023/a:1018806508474. Dig Dis Sci. 1997. PMID: 9246044
Why we should treat chronic viral hepatitis.
King PD. King PD. Postgrad Med. 1996 Sep;100(3):68-70, 73; discussion 73, 78. doi: 10.3810/pgm.1996.09.69. Postgrad Med. 1996. PMID: 8795647 Review. No abstract available.
The development of hepatic granulomas following interferon-alpha2b therapy for chronic hepatitis C infection.
Ryan BM, McDonald GS, Pilkington R, Kelleher D. Ryan BM, et al. Eur J Gastroenterol Hepatol. 1998 Apr;10(4):349-51. doi: 10.1097/00042737-199804000-00013. Eur J Gastroenterol Hepatol. 1998. PMID: 9855053
Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
Vento S, Di Perri G, Garofano T, Cosco L, Concia E, Ferraro T, Bassetti D. Vento S, et al. Lancet. 1989 Oct 14;2(8668):926. doi: 10.1016/s0140-6736(89)91595-x. Lancet. 1989. PMID: 2571851 No abstract available.
Chronic viral hepatitis and use of interferon. Whom are we treating?
Koretz RL. Koretz RL. Postgrad Med. 1996 Sep;100(3):55-7, 61-2, 68. doi: 10.3810/pgm.1996.09.68. Postgrad Med. 1996. PMID: 8795646 Review.

See all similar articles

Cited by

Hepatic granulomas: a 10 year single centre experience.
Gaya DR, Thorburn D, Oien KA, Morris AJ, Stanley AJ. Gaya DR, et al. J Clin Pathol. 2003 Nov;56(11):850-3. doi: 10.1136/jcp.56.11.850. J Clin Pathol. 2003. PMID: 14600131 Free PMC article.
Granulomatous liver diseases.
Mironova M, Gopalakrishna H, Rodriguez Franco G, Holland SM, Koh C, Kleiner DE, Heller T. Mironova M, et al. Hepatol Commun. 2024 Mar 18;8(4):e0392. doi: 10.1097/HC9.0000000000000392. eCollection 2024 Apr 1. Hepatol Commun. 2024. PMID: 38497932 Free PMC article. Review.
Prevalence of hepatic granulomas in chronic hepatitis B.
Tahan V, Ozaras R, Lacevic N, Ozden E, Yemisen M, Ozdogan O, Mert A, Tabak F, Avsar E, Celikel CA, Ozbay G, Kalayci C, Senturk H, Tozun N. Tahan V, et al. Dig Dis Sci. 2004 Oct;49(10):1575-7. doi: 10.1023/b:ddas.0000043366.18578.15. Dig Dis Sci. 2004. PMID: 15573907

References

1. Lancet. 1992 Jan 11;339(8785):123-4 - PubMed
1. Hepatology. 1986 May-Jun;6(3):349-53 - PubMed
1. Gastroenterology. 1991 Sep;101(3):840-2 - PubMed
1. Hepatology. 1988 May-Jun;8(3):712-7 - PubMed
1. Hepatology. 1991 Dec;14(6):969-74 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information